Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc.ARQT · Entity 4236 | Director | June 05, 2026 | June 10, 2026 |
| INTUITIVE SURGICAL INCISRG · Entity 2878 | Director | April 30, 2026 | May 01, 2026 |
| Sienna Biopharmaceuticals, Inc.SNNA · Entity 154554 | Director | May 30, 2019 | June 03, 2019 |
| Unity Biotechnology, Inc.UBX · Entity 77428 | Director | June 21, 2024 | June 21, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcutis Biotherapeutics, Inc.
Report date June 05, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,901 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 5,778 · Balance 27,901 F1: Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 28, 2025, maintained by the Company. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.23 · Expires 2036-06-05 | Direct | 16,667 |
Reported balance
After 2026-06-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-05 · Grant · Acquired 16,667 · Balance 16,667 F3: The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. |
| Common StockSEC Table I · non-derivative | IndirectBy Leonard Family Trust dated August 28, 1996 | 1,750 |
Reported balance
Holding disclosure · report date 2026-06-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,750 F2: Shares held by Leonard Family Trust dated August 28, 1996, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 28, 2025, maintained by the Company.
F2: Shares held by Leonard Family Trust dated August 28, 1996, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F3: The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.
INTUITIVE SURGICAL INC
Report date April 30, 2026 · Filed May 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 901 |
Reported balance
After 2026-04-30 transaction · row 1
1 source rowRow 1 · 2026-04-30 · Exercise / conversion · Acquired 531 · Balance 901 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-04-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-30 · Exercise / conversion · Disposed 531 · Balance 0 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. |
| Restricted Stock Units - 4-30-2026SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 554 |
Reported balance
After 2026-04-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-30 · Grant · Acquired 554 · Balance 554 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.
Sienna Biopharmaceuticals, Inc.
Report date May 30, 2019 · Filed June 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.22 · Expires 2029-05-30 | Direct | 25,000 |
Reported balance
After 2019-05-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-30 · Grant · Acquired 25,000 · Balance 25,000 F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date.
Unity Biotechnology, Inc.
Report date June 21, 2024 · Filed June 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.38 · Expires 2034-06-20 | Direct | 10,000 |
Reported balance
After 2024-06-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-21 · Grant · Acquired 10,000 · Balance 10,000 F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 21, 2024 or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 21, 2024 or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2020 Filed Jun 22, 2020 17:23 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $9.14 | $0.00 |
DisclosureSEC source: 0000899243-20-017383 · doc4.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-06-17 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable with respect to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from June 18, 2020, subject to the Reporting Person's continued service relationship with the Issuer on each vesting date. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 766 | $0.00 Strike: $513.22 | $0.00 |
DisclosureSEC source: 0001567619-20-008487 · doc1.xml · derivative · entry 4 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766 Underlying: Common Stock · 766 shares Expires 2030-04-23 F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of April 23, 2020 or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-008487 · doc1.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255 Underlying: Common Stock · 255 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of April 23, 2020 or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. F3 · derivative.expiration_date: 100% of the RSUs shall vest on the earlier of the one year anniversary of April 23, 2020 or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-008487 · doc1.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 262 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On April 25, 2019, the Reporting Person was granted 262 RSUs, vesting as to 100% on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders. F2 · derivative.expiration_date: On April 25, 2019, the Reporting Person was granted 262 RSUs, vesting as to 100% on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:01 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 262 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-008487 · doc1.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 01:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,545 | $0.00 Strike: $271.48 | $0.00 |
DisclosureSEC source: 0001035267-20-000034 · edgardoc.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,545 shares Expires 2027-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on October 30, 2020. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 01:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 1,545 | $600.00 | $927,000.00 |
DisclosureSEC source: 0001035267-20-000034 · edgardoc.xml · nonDerivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on October 30, 2020. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 01:44 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,545 | $271.48 | $419,441.70 |
DisclosureSEC source: 0001035267-20-000034 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on October 30, 2020. Read SEC document |
| December 27, 2019 Filed Feb 12, 2020 17:21 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GiftCommon Stock, $0.0001 par value | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-004324 · doc5.xml · nonDerivative · entry 3 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 500,000 F3 · ownership.nature: The shares are held by Keith Richard Leonard, Jr. 2019 Retained Annuity Trust dated 16 Dec 2019. Read SEC document |
| December 27, 2019 Filed Feb 12, 2020 17:21 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GiftCommon Stock, $0.0001 par value | 383,475 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-004324 · doc5.xml · nonDerivative · entry 2 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F2 · ownership.nature: The shares were held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest. Read SEC document |
| December 27, 2019 Filed Feb 12, 2020 17:21 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GiftCommon Stock, $0.0001 par value | 116,525 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-004324 · doc5.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,257 F1 · balance_after: Includes Restricted Stock Units which vest over time measured from the grant date. Read SEC document |
| November 01, 2019 Filed Nov 7, 2019 18:42 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GiftCommon Stock | 513 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-19-000151 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332 F1 · kind: The filer gifted shares acquired through an RSU award granted 4/2017 to the Leonard Charitable Reminder Unit Trust (CRUT). Mr. Leonard is not an investment advisor for this trust. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 20:00 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GrantStock Option (Right to Buy) · Derivative | 35,525 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0000899243-19-024073 · doc4.xml · derivative · entry 5 Leonard Keith R · CIK 0001416180 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,525 Underlying: Common Stock · 35,525 shares Expires 2028-01-28 F5 · shares: On January 29, 2018, Reporting Person was granted an option exercisable for 142,102 shares. Twenty-five percent (25%) of the shares was subject to vesting pursuant to the achievement of a clinical development milestone; in this case proof of concept that treatment with a senolytic drug meaningfully ameliorates a human disease. On September 19, 2019, Issuer's Board of Directors determined that such milestone was achieved. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 16:15 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GrantStock Option (Right to Buy) · Derivative | 260,000 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013875 · doc1.xml · derivative · entry 5 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Stock · 260,000 shares Expires 2029-06-19 F5 · derivative.exercise_date: The shares subject to the option vest and become exercisable in 48 successive, equal monthly installments measured from June 20, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 16:15 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013875 · doc1.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,782 F1 · shares: RSUs which vest 1/3 annually over 3 years measured from June 20, 2019. Read SEC document |
| June 19, 2019 Filed Jun 19, 2019 21:14 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001567619-19-013725 · doc1.xml · derivative · entry 5 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,364,100 Underlying: Common Stock · 20,000 shares Expires 2027-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest and become exercisable in 48 successive, equal monthly installments measured from October 26, 2016, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| June 19, 2019 Filed Jun 19, 2019 21:14 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | Exercise / conversionCommon Stock | 20,000 | $3.40 | $68,000.00 |
DisclosureSEC source: 0001567619-19-013725 · doc1.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 19:35 UTC | Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 | GrantStock Options (Right to buy) · Derivative | 25,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001562180-19-003241 · primarydocument.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-05-30 F1 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date. Read SEC document |
| April 25, 2019 Filed Apr 26, 2019 19:36 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 262 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-19-000064 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262 Underlying: Common Stock · 262 shares Expires 2020-04-26 F2 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| April 25, 2019 Filed Apr 26, 2019 19:36 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 786 | $0.00 Strike: $517.78 | $0.00 |
DisclosureSEC source: 0001035267-19-000064 · edgardoc.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786 Underlying: Common Stock · 786 shares Expires 2029-04-25 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| April 19, 2019 Filed Apr 23, 2019 15:51 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 332 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-19-000043 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 332 shares Expires 2022-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The RSUs fully vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholders meeting. F2 · derivative.exercise_date: Restricted Stock Units (RSUs) are granted pursuant to the 2010 Incentive Award Plan. The RSUs fully vest on the first anniversary of the date of grant. Read SEC document |
| April 19, 2019 Filed Apr 23, 2019 15:51 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-19-000043 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The RSUs fully vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholders meeting. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 17:14 UTC | Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 | PurchaseCommon Stock | 100,000 | $2.50 | $250,000.00 |
DisclosureSEC source: 0001562180-19-001423 · primarydocument.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · kind: The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's public offering at the offering price of $2.50 per share. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:40 UTC | Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 | GrantStock Options (Right to buy) · Derivative | 10,000 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0001562180-18-002847 · primarydocument.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-06-01 F1 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date. Read SEC document |
| May 07, 2018 Filed May 7, 2018 18:20 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | ConversionSeries C Preferred Stock · Derivative | 1,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-022045 · doc1.xml · derivative · entry 7 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F1 · derivative.exercise_date: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F5 · derivative.expiration_date: The expiration date is not relevant to the conversion of these securities. Read SEC document |
| May 07, 2018 Filed May 7, 2018 18:20 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | ConversionSeries B Preferred Stock · Derivative | 148,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-022045 · doc1.xml · derivative · entry 6 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 148,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F1 · derivative.exercise_date: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F5 · derivative.expiration_date: The expiration date is not relevant to the conversion of these securities. F3 · ownership.nature: The shares are directly held by Pathfinder Investment Fund, LLC, a limited liability company in which the Reporting Person holds a controlling interest. Read SEC document |
| May 07, 2018 Filed May 7, 2018 18:20 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | ConversionSeries B Preferred Stock · Derivative | 383,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-022045 · doc1.xml · derivative · entry 5 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 383,475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F1 · derivative.exercise_date: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F5 · derivative.expiration_date: The expiration date is not relevant to the conversion of these securities. F2 · ownership.nature: The shares are directly held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest. Read SEC document |
| May 07, 2018 Filed May 7, 2018 18:20 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | ConversionCommon Stock | 1,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-022045 · doc1.xml · nonDerivative · entry 3 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. Read SEC document |
| May 07, 2018 Filed May 7, 2018 18:20 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | ConversionCommon Stock | 148,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-022045 · doc1.xml · nonDerivative · entry 2 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 148,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F3 · ownership.nature: The shares are directly held by Pathfinder Investment Fund, LLC, a limited liability company in which the Reporting Person holds a controlling interest. Read SEC document |
| May 07, 2018 Filed May 7, 2018 18:20 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | ConversionCommon Stock | 383,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-022045 · doc1.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 383,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F2 · ownership.nature: The shares are directly held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest. Read SEC document |
| May 02, 2018 Filed May 4, 2018 18:21 UTC | Unity Biotechnology, Inc. UBX · Entity 77428 | GrantStock Option (Right to Buy) · Derivative | 67,797 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001140361-18-021813 · doc1.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,797 Underlying: Common Stock · 67,797 shares Expires 2028-05-01 F1 · derivative.exercise_date: The shares subject to the option vest as to 25% of the shares on the one-year anniversary of May 2, 2018, and 1/48th of the shares shall vest on each monthly anniversary thereafter, subject to the optionee remainining a service provider to the Issuer on each such vesting date. Read SEC document |
| April 19, 2018 Filed Apr 20, 2018 00:18 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 332 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-18-000053 · edgardoc.xml · derivative · entry 4 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332 Underlying: Common Stock · 332 shares Expires 2022-04-19 F4 · derivative.exercise_date: Restricted Stock Units (RSUs) are granted pursuant to the 2010 Incentive Award Plan. The RSUs fully vest on the first anniversary of the date of grant. Read SEC document |
| April 19, 2018 Filed Apr 20, 2018 00:18 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 513 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-18-000053 · edgardoc.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 513 shares Expires 2018-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| April 19, 2018 Filed Apr 20, 2018 00:18 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 996 | $0.00 Strike: $462.71 | $0.00 |
DisclosureSEC source: 0001035267-18-000053 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 996 Underlying: Common Stock · 996 shares Expires 2028-04-19 F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| April 19, 2018 Filed Apr 20, 2018 00:18 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 513 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-18-000053 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were acquired from the vest and release of an RSU grant previously issued to the Filer. Read SEC document |
| November 01, 2017 Filed Nov 2, 2017 11:51 UTC | Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 | GrantStock Option (Right to Buy) · Derivative | 5,315 | $0.00 Strike: $19.91 | $0.00 |
DisclosureSEC source: 0001140361-17-040668 · doc1.xml · derivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,315 Underlying: Common Stock · 5,315 shares Expires 2027-11-01 F1 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:27 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 327 | $0.00 Strike: $641.91 | $0.00 |
DisclosureSEC source: 0001035267-17-000131 · edgardoc.xml · derivative · entry 7 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 327 shares Expires 2026-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options will vest 100% on the earlier of the first anniversary of the date of grant or the date of the next annual stockholders meeting. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:27 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 100 | $0.00 Strike: $526.59 | $0.00 |
DisclosureSEC source: 0001035267-17-000131 · edgardoc.xml · derivative · entry 6 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100 shares Expires 2026-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:27 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 427 | $1,000.00 | $427,000.00 |
DisclosureSEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 5 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These shares were sold pursuant to a 10b5-1 Trading Plan entered into on January 27, 2017. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:27 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 100 | $1,000.00 | $100,000.00 |
DisclosureSEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 4 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427 F1 · kind: These shares were sold pursuant to a 10b5-1 Trading Plan entered into on January 27, 2017. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:27 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 100 | $526.59 | $52,659.00 |
DisclosureSEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:27 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 327 | $1,000.00 | $327,000.00 |
DisclosureSEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427 F1 · kind: These shares were sold pursuant to a 10b5-1 Trading Plan entered into on January 27, 2017. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:27 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 327 | $641.91 | $209,904.57 |
DisclosureSEC source: 0001035267-17-000131 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2017 Filed Aug 1, 2017 16:22 UTC | Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 | ConversionSeries A-3 Preferred Stock · Derivative | 31,784 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-029593 · doc1.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 31,784 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F1 · derivative.exercise_date: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F5 · derivative.expiration_date: The expiration date is not relevant to the conversion of these securities. F2 · ownership.nature: The shares are directly held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest. Read SEC document |
| August 01, 2017 Filed Aug 1, 2017 16:22 UTC | Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 | PurchaseCommon Stock | 16,700 | $15.00 | $250,500.00 |
DisclosureSEC source: 0001140361-17-029593 · doc1.xml · nonDerivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,700 F3 · kind: The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's initial public offering at the offering price of $15.00 per share. F4 · ownership.nature: The shares are directly held by the Leonard Family Trust. Read SEC document |
| August 01, 2017 Filed Aug 1, 2017 16:22 UTC | Sienna Biopharmaceuticals, Inc. SNNA · Entity 154554 | ConversionCommon Stock | 31,784 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-029593 · doc1.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 31,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering. F2 · ownership.nature: The shares are directly held by Andalucia Ventures LLC, a limited liability company in which the Reporting Person holds a controlling interest. Read SEC document |
| April 20, 2017 Filed Apr 21, 2017 21:25 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionRestricted Stock Units · Derivative | 327 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-17-000065 · edgardoc.xml · derivative · entry 4 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 327 shares Expires 2020-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| April 20, 2017 Filed Apr 21, 2017 21:25 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantRestricted Stock Units · Derivative | 171 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-17-000065 · edgardoc.xml · derivative · entry 3 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171 Underlying: Common Stock · 171 shares Expires 2018-02-21 F3 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| April 20, 2017 Filed Apr 21, 2017 21:25 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 515 | $0.00 Strike: $814.45 | $0.00 |
DisclosureSEC source: 0001035267-17-000065 · edgardoc.xml · derivative · entry 2 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515 Underlying: Common Stock · 515 shares Expires 2027-04-20 F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. Read SEC document |
| April 20, 2017 Filed Apr 21, 2017 21:25 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 327 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-17-000065 · edgardoc.xml · nonDerivative · entry 1 Leonard Keith R · CIK 0001416180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired from the vest and release of an RSU grant previously issued to the Filer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.